Clinical Trial Update: ALG-LungCancerRegistry (SAFRO2202)

View source ↗

Summary

An ongoing clinical trial registry in Algeria (SAFRO2202) for lung cancer is recruiting patients with non-small cell lung cancer, small cell lung cancer, and ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor
• Lung Cancer
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: Société Algérienne de Formation et de Recherche en Oncologie | Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung | Status: RECRUITING